APO RESEARCH · REPORT
Insulin Pen
Insulin Pen is a kind of insulin injection device, slightly larger in size than the pen, insulin refill in the pen. It’s easy to carry at users’ ease. The way to function is to fit with specific refill filled with insulin, fix the needle and pull off the needle cover. The operation is very convenient.
Product & engineering
Understand the product.
Insulin Pen is a kind of insulin injection device, slightly larger in size than the pen, insulin refill in the pen. It’s easy to carry at users’ ease. The way to function is to fit with specific refill filled with insulin, fix the needle and pull off the needle cover. The operation is very convenient.
Insulin pen prevents the patient from the cumbersome procedure of extraction with a syringe from the insulin bottle; reduce embarrassment in public; supply convenience for poor vision and even blindness sufferers.
Selected research
Industry Research
Insulin Pen Industry Research Report 2026
Market perspective
Insulin Pen is a kind of insulin injection device, slightly larger in size than the pen, insulin refill in the pen. It’s easy to carry at users’ ease. The way to function is to fit with specific refill filled with insulin, fix the needle and pull off the needle cover. The operation is very convenient.
Insulin pen prevents the patient from the cumbersome procedure of extraction with a syringe from the insulin bottle; reduce embarrassment in public; supply convenience for poor vision and even blindness sufferers.
EU is the largest Insulin Pen market with about 48% market share. Asia is follower, accounting for about 27% market share.
Read the full market overview
The key players are Novo Nordisk, Eli Lilly, Sanofi, BD, Ypsomed Holding, Dongbao, Owen Mumford, Ganlee etc. Top 3 companies occupied about 69% market share.
Report Scope
This report quantifies the global Insulin Pen market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Insulin Pen Market by Company
Novo Nordisk
Eli Lilly
Sanofi
BD
Ypsomed Holding
Dongbao
Owen Mumford
Ganlee
Insulin Pen Segment by Type
Reusable Insulin Pen
Disposable Insulin Pen
Insulin Pen Segment by Application
Hospitals
Clinics
The Chemist's Shops
Insulin Pen Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insulin Pen market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Insulin Pen and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insulin Pen.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Insulin Pen manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Insulin Pen by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Insulin Pen in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Reusable Insulin Pen
- Disposable Insulin Pen
Applications
- Hospitals
- Clinics
- The Chemist's Shops
Companies covered
- Novo Nordisk
- Eli Lilly
- Sanofi
- BD
- Ypsomed Holding
- Dongbao
- Owen Mumford
- Ganlee
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Insulin Pen Market Size (2021-2032)
- 2.2.2 Global Insulin Pen Sales (2021-2032)
- 2.2.3 Global Insulin Pen Market Average Price (2021-2032)
- 2.3 Insulin Pen by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Reusable Insulin Pen
- 2.3.3 Disposable Insulin Pen
- 2.4 Insulin Pen by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Clinics
- 2.4.4 The Chemist's Shops
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Insulin Pen Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Insulin Pen Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Insulin Pen Revenue of Manufacturers (2021-2026)
- 3.4 Global Insulin Pen Average Price by Manufacturers (2021-2026)
- 3.5 Global Insulin Pen Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Insulin Pen, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Insulin Pen, Product Type & Application
- 3.8 Global Manufacturers of Insulin Pen, Established Date
- 3.9 Global Insulin Pen Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Novo Nordisk
- 4.1.1 Novo Nordisk Company Information
- 4.1.2 Novo Nordisk Business Overview
- 4.1.3 Novo Nordisk Insulin Pen Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Novo Nordisk Insulin Pen Product Portfolio
- 4.1.5 Novo Nordisk Recent Developments
- 4.2 Eli Lilly
- 4.2.1 Eli Lilly Company Information
- 4.2.2 Eli Lilly Business Overview
- 4.2.3 Eli Lilly Insulin Pen Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Eli Lilly Insulin Pen Product Portfolio
- 4.2.5 Eli Lilly Recent Developments
- 4.3 Sanofi
- 4.3.1 Sanofi Company Information
- 4.3.2 Sanofi Business Overview
- 4.3.3 Sanofi Insulin Pen Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sanofi Insulin Pen Product Portfolio
- 4.3.5 Sanofi Recent Developments
- 4.4 BD
- 4.4.1 BD Company Information
- 4.4.2 BD Business Overview
- 4.4.3 BD Insulin Pen Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 BD Insulin Pen Product Portfolio
- 4.4.5 BD Recent Developments
- 4.5 Ypsomed Holding
- 4.5.1 Ypsomed Holding Company Information
- 4.5.2 Ypsomed Holding Business Overview
- 4.5.3 Ypsomed Holding Insulin Pen Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Ypsomed Holding Insulin Pen Product Portfolio
- 4.5.5 Ypsomed Holding Recent Developments
- 4.6 Dongbao
- 4.6.1 Dongbao Company Information
- 4.6.2 Dongbao Business Overview
- 4.6.3 Dongbao Insulin Pen Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Dongbao Insulin Pen Product Portfolio
- 4.6.5 Dongbao Recent Developments
- 4.7 Owen Mumford
- 4.7.1 Owen Mumford Company Information
- 4.7.2 Owen Mumford Business Overview
- 4.7.3 Owen Mumford Insulin Pen Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Owen Mumford Insulin Pen Product Portfolio
- 4.7.5 Owen Mumford Recent Developments
- 4.8 Ganlee
- 4.8.1 Ganlee Company Information
- 4.8.2 Ganlee Business Overview
- 4.8.3 Ganlee Insulin Pen Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Ganlee Insulin Pen Product Portfolio
- 4.8.5 Ganlee Recent Developments
5 Global Insulin Pen Market Scenario by Region
- 5.1 Global Insulin Pen Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Insulin Pen Sales by Region: 2021-2032
- 5.2.1 Global Insulin Pen Sales by Region: 2021-2026
- 5.2.2 Global Insulin Pen Sales by Region: 2027-2032
- 5.3 Global Insulin Pen Revenue by Region: 2021-2032
- 5.3.1 Global Insulin Pen Revenue by Region: 2021-2026
- 5.3.2 Global Insulin Pen Revenue by Region: 2027-2032
- 5.4 North America Insulin Pen Market Facts & Figures by Country
- 5.4.1 North America Insulin Pen Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Insulin Pen Sales by Country (2021-2032)
- 5.4.3 North America Insulin Pen Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Insulin Pen Market Facts & Figures by Country
- 5.5.1 Europe Insulin Pen Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Insulin Pen Sales by Country (2021-2032)
- 5.5.3 Europe Insulin Pen Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Insulin Pen Market Facts & Figures by Country
- 5.6.1 Asia Pacific Insulin Pen Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Insulin Pen Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Insulin Pen Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Insulin Pen Market Facts & Figures by Country
- 5.7.1 South America Insulin Pen Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Insulin Pen Sales by Country (2021-2032)
- 5.7.3 South America Insulin Pen Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Insulin Pen Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Insulin Pen Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Insulin Pen Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Insulin Pen Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Insulin Pen Sales by Type (2021-2032)
- 6.1.1 Global Insulin Pen Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Insulin Pen Sales Market Share by Type (2021-2032)
- 6.2 Global Insulin Pen Revenue by Type (2021-2032)
- 6.2.1 Global Insulin Pen Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Insulin Pen Revenue Market Share by Type (2021-2032)
- 6.3 Global Insulin Pen Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Insulin Pen Sales by Application (2021-2032)
- 7.1.1 Global Insulin Pen Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Insulin Pen Sales Market Share by Application (2021-2032)
- 7.2 Global Insulin Pen Revenue by Application (2021-2032)
- 7.2.1 Global Insulin Pen Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Insulin Pen Revenue Market Share by Application (2021-2032)
- 7.3 Global Insulin Pen Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Insulin Pen Value Chain Analysis
- 8.1.1 Insulin Pen Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Insulin Pen Production Mode & Process
- 8.2 Insulin Pen Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Insulin Pen Distributors
- 8.2.3 Insulin Pen Customers
9 Global Insulin Pen Analyzing Market Dynamics
- 9.1 Insulin Pen Industry Trends
- 9.2 Insulin Pen Industry Drivers
- 9.3 Insulin Pen Industry Opportunities and Challenges
- 9.4 Insulin Pen Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst